Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tournigand

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
La Revue De Medecine Interne|February 24, 2009
[What are the new therapeutic strategies in metastatic colorectal cancer including biotherapies?]C Tournigand, L Bengrine-Lefevre
La Revue De Medecine Interne|February 22, 2011
[Cardiovascular toxicity of anti-angiogenic therapy]O El Mesbahi, C Tournigand, Z Benbrahim
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 11, 2013
The evolving role of oxaliplatin in the management of colorectal cancerA de Gramont, H J Schmoll, A Cervantes, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)A de Gramont, C Louvet, T André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimenT André, C Louvet, E Raymond, et al.
La Revue De Medecine Interne|January 1, 1997
[Epithelioid sarcoma. Diagnostic and therapeutic aspects apropos of a coccygeal localization]C Tournigand, O Bernard, T Cruel, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Concordance between patient-reported outcomes and CTCAE clinician-reported toxicities during outpatient chemotherapy courses: a retrospective cohort study in routine careS Huynh-Dagher, T-A Duong, C Tournigand, et al.
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Chemotherapy of colorectal cancers with metastases]A de Gramont, C Louvet, T André, et al.
Lupus|December 22, 1999
Minocycline-induced clinical and biological lupus-like diseaseC Tournigand, T Généreau, M Prudent, et al.
Gastroenterologie Clinique Et Biologique|July 13, 2001
[Meningeal carcinomatosis in gastric cancer]L Vedrine, P Artru, C Tournigand, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
La Revue De Medecine Interne|February 24, 2009
[What are the new therapeutic strategies in metastatic colorectal cancer including biotherapies?]C Tournigand, L Bengrine-Lefevre
La Revue De Medecine Interne|February 22, 2011
[Cardiovascular toxicity of anti-angiogenic therapy]O El Mesbahi, C Tournigand, Z Benbrahim
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 11, 2013
The evolving role of oxaliplatin in the management of colorectal cancerA de Gramont, H J Schmoll, A Cervantes, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)A de Gramont, C Louvet, T André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimenT André, C Louvet, E Raymond, et al.
La Revue De Medecine Interne|January 1, 1997
[Epithelioid sarcoma. Diagnostic and therapeutic aspects apropos of a coccygeal localization]C Tournigand, O Bernard, T Cruel, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Concordance between patient-reported outcomes and CTCAE clinician-reported toxicities during outpatient chemotherapy courses: a retrospective cohort study in routine careS Huynh-Dagher, T-A Duong, C Tournigand, et al.
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Chemotherapy of colorectal cancers with metastases]A de Gramont, C Louvet, T André, et al.
Lupus|December 22, 1999
Minocycline-induced clinical and biological lupus-like diseaseC Tournigand, T Généreau, M Prudent, et al.
Gastroenterologie Clinique Et Biologique|July 13, 2001
[Meningeal carcinomatosis in gastric cancer]L Vedrine, P Artru, C Tournigand, et al.
Pageof 5